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E-mail address: colin.sutherland@lshtm.ac.uk (C.J.It has been proposed that ovale malaria in humans is caused by two closely related but distinct species of
malaria parasite, Plasmodium ovale curtisi and Plasmodium ovale wallikeri. It was recently shown that
these two parasite types are sympatric at the country level. However, it remains possible that localised
geographic, temporal or ecological barriers exist within endemic countries which prevent recombination
between the genomes of the two species. Here, using conventional and real-time quantitative PCR (qPCR)
methods speciﬁcally designed to discriminate P. o. curtisi and P. o. wallikeri, it is shown that both species
are present among clinic attendees in Congo-Brazzaville, and occur simultaneously both in lake-side and
inland districts in Uganda and on Bioko Island, Equatorial Guinea. Thus P. o. curtisi and P. o. wallikeri in
these localities are exactly sympatric in both time and space. These ﬁndings are consistent with the exis-
tence of a biological barrier, rather than geographical or ecological factors, preventing recombination
between P. o. curtisi and P. o. wallikeri. In cross-sectional surveys carried out in Uganda and Bioko, our
results show that infections with P. ovale spp. are more common than previously thought, occurring at
a frequency of 1–6% in population samples, with both proposed species contributing to ovale malaria
in six sites. Malaria elimination programmes in Africa need to include strategies for control of P. o. curtisi
and P. o. wallikeri.
 2011 Australian Society for Parasitology Inc. Published by Elsevier Ltd. Open access under CC BY license.1. Introduction
The human malaria agent Plasmodium ovale was described by
Stevens in 1922. Since that time, relatively little attention has been
paid to ovale malaria, which is considered to be uncommon, mild
in clinical presentation and easily treated with the conventional
antimalarial drug chloroquine (Mueller et al., 2007). Difﬁculties
in performing deﬁnitive species-level diagnosis in endemic set-
tings are likely to have resulted in a systematic under-estimation
of the number of cases of ovale malaria across its tropical range;
analysis of UK reference laboratory data over a 20 year periodInc. Published by Elsevier Ltd.
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Sutherland).
Opestrongly suggests that a substantial burden of ovale malaria occurs
in sub-Saharan Africa (Sutherland et al., 2010). Plasmodium ovale
has also proved difﬁcult to identify using species-speciﬁc molecu-
lar tests, as a sizeable subset of isolates do not produce the ex-
pected DNA ampliﬁcation products with established ovale-
speciﬁc primers targeting the ssrRNA gene, and may be missed
by standard rapid diagnostic tests (Calderaro et al., 2007; Talman
et al., 2007). Sequencing of rRNA genes from two well-character-
ised isolates of P. ovale ﬁrst prompted the suggestion that this spe-
cies was dimorphic, and raised the possibility that two sub-species
might exist (Li et al., 1995). Analysis of loci other than rRNA genes
supported the idea that this dimorphism was multigenic, leading
to the concept of ‘‘variant’’ ovale parasites (Tachibana et al.,
2002; Win et al., 2004; Calderaro et al., 2007). In a study of P. ovale
conducted by researchers from Mahidol University, Bangkok, and
the UK Malaria Reference Laboratory (UKMRL), London, polymor-n access under CC BY license.
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haplotypes of each locus were identiﬁed and these did not recom-
bine in any of the parasites examined. Thus P. ovale dimorphism
was proposed to reﬂect the existence of two fully distinct ovale
malaria species, which were unexpectedly shown to be broadly
sympatric, at the country level, in both Africa and Asia (Sutherland
et al., 2010). These two proposed species have been named Plasmo-
dium ovale curtisi and Plasmodium ovale wallikeri.
The recognition that two separate parasite species may be the
agents of ovale malaria raises many questions, but perhaps the
most intriguing puzzle is the unknown nature of the mechanism
that keeps these parasites genetically separate, when they are
found in the same countries in Asia and in Africa. The elucidation
of any biological/genetic mechanism or mechanisms separating
P. o. curtisi and P. o. wallikeri requires detailed investigation of
the biology of these two pathogens, which is hampered by the lack
of a system for in vitro cultivation and thus requires in vivo and
ex vivo approaches. Physical separation is a plausible non-biologi-
cal barrier to recombination and could be caused by geographic
discontinuities in within-country distribution or temporal causes
such as adaptation to transmission at different times of the year.
Such physical barriers could conceivably prevent both species from
being ingested by a feeding Anopheles mosquito in a single blood-
meal, the prerequisite for meiotic recombination. We endeavored
to determine whether both P. o. curtisi and P. o. wallikeri could be
identiﬁed in the same community at the same time, using samples
from febrile malaria patients presenting to clinics in Congo-Brazza-
ville, or from cross-sectional parasitological sampling over one or a
few days in single communities in Uganda and in Bioko Island,
Equatorial Guinea. This parasite material was collected in the
course of studies of other Plasmodium spp. but in each site a mea-
surable contribution of P. o. curtisi and P. o. wallikeri to the overall
prevalence of parasitaemia was demonstrated.2. Materials and methods
2.1. Parasite sample collection and DNA extraction
2.1.1. Congo-Brazzaville
Blood samples were taken from febrile patients attending
health centres in three separate locations within the Republic of
Congo between 2005 and 2007 as previously described (Culleton
et al., 2008, 2009). Sampled health centres include Madibou and
Tenrikyo within Brazzaville, the capital of the Republic of Congo,
Mbota in Pointe-Noire (a city on the west coast of the country)
and Gamboma, a town in the east. Samples collected in 2005 were
collected on Whatman FTA ﬁlter paper and processed as previ-
ously described (Culleton et al., 2008). All remaining samples were
collected on Whatman 31ETCHR ﬁlter paper and DNA extraction
was performed using the EZ1 BioRobot™ (QIAGEN, Hilden,
Germany) according to the manufacturer’s instructions. Results
of initial PCR species diagnoses, performed on all samples except
those from Pointe-Noire in 2007, which were diagnosed by micros-
copy alone, have been presented previously (Culleton et al., 2008).
Plasmodium ovale-positive puriﬁed DNA samples were shipped to
London, UK for this study.2.1.2. Buliisa and Mayuge districts, Uganda
Single ﬁnger-prick blood samples were collected onto
Whatman 3M ﬁlter paper from 1850 mothers and young children
enrolled in a longitudinal study of schistosomiasis and malaria
infection in six lakeside communities (Bugoigo, Walukuba, Piida,
Bugoto, Bukoba and Lwanika) in Buliisa and Mayuge Districts,
Uganda (Betson et al., 2010). Samples from each village were col-
lected over a period of 3–5 days. Samples were transported tothe London School of Hygiene and Tropical Medicine, (LSHTM),
UK for DNA extraction by a modiﬁcation of the Chelex method,
as previously described (Dlamini et al., 2010), and were screened
using a species-speciﬁc probe-based real-time PCR assay in order
to detect P. ovale parasite DNA for testing in the curtisi – wallikeri
discrimination assay (Shokoples et al., 2009).2.1.3. Apac district, northern Uganda
A health facility-based survey was conducted in the parish of
Abedi in Apac district, northern Uganda. This area is hyperendemic
for Plasmodium falciparum malaria with an estimated entomologi-
cal inoculation rate >1000 infectious bites per person per year
(Okello et al., 2006). All people attending a local health facility,
regardless of reasons for presentation, were asked to donate a
small blood sample for microscopic slide preparation and blood
spot collection on ﬁlter paper (Whatman 3MM). DNA was
extracted from 241 samples, with a microscopical prevalence of
P. falciparum of 37.6% (89/237) and no other parasite species were
identiﬁed by microscopy. DNA was extracted by the Chelex
Method (Dlamini et al., 2010) for microscopically positive and neg-
ative samples.2.1.4. Bioko Island, Equatorial Guinea
Intensive malaria control interventions have been carried out
on Bioko Island, Equatorial Guinea, by The Bioko Island Malaria
Control Project (BIMCP) in collaboration with the Ministry of
Health and Social Welfare of Equatorial Guinea. As part of the eval-
uation of the BIMCP, annual malaria indicator surveys have been
carried out since 2004 (Kleinschmidt et al., 2009). During the
2009 annual survey, which was carried out across the whole island
between July and September of that year, blood samples were
collected from 209 individuals in the town of Luba and from 110
individuals in Punta Europa Sacriba. Samples were spotted onto
glass-ﬁbre paper (Filtermat A, Wallac, Finland) and shipped to
LSHTM, UK for DNA extraction by the Chelex method (Dlamini
et al., 2010). Initial screening for the presence of parasites belong-
ing to the genus Plasmodium was carried out using the loop-acti-
vated ampliﬁcation (LAMP) assay of Polley et al. (2010). The
species present in positive samples were discriminated by the
nested PCR of Snounou and colleagues, using a modiﬁed primer
set to detect all P. ovale parasites (Calderaro et al., 2007).2.2. PCR ampliﬁcation and DNA sequencing
Genomic DNA sequences were obtained as previously described
(Dlamini et al., 2010) except that removal of incorporated primers
and nucleotides from PCR products was performed using the
ExoSAP-IT protocol (GE Healthcare). Sequences were aligned in
Clustal V (Fig. 1). Conventional PCR and sequencing reactions were
performed on a GRI Tetrad thermocycler. For ampliﬁcation of potra
(encoding the P. ovale sp. tryptophan-rich antigen) loci from ﬁeld
samples, the primers presented in Table 1 and Fig. 1 were used
in a nested procedure, with PoTRA3 ampliﬁcation followed by
PoTRA5 ampliﬁcation.
Real-time ampliﬁcation assays were performed using the
Quantitect Sybr Green PCR kit (Qiagen) on Corbett Rotorgene
RG3000 and RG6000 thermo-cyclers, and output was measured
by detecting SYBR green incorporation on the FAM ﬂuorescence
detection channel. PCR primers and cycling conditions were as pre-
viously described (Sutherland et al., 2010) or are given in Table 1.
For a subset of samples, additional ampliﬁcation and sequenc-
ing of the po3gp locus, encoding glyceraldehyde-3-phosphatase,
was carried out exactly as described (Sutherland et al., 2010) to
conﬁrm species designations using a third gene (data not shown).
Fig. 1. Discrimination between Plasmodium ovale curtisi (Poc) and Plasmodium ovale wallikeri (Pow) using nested PCR ampliﬁcation of the repeat region of poctra and powtra
genes. (A) Alignment of the translated amino acid sequence encoded by a large portion of the P. ovale sp. tryptophan-rich antigen gene (potra), showing the four different
forms sequenced (Poc, Poc + 6, Pow1, Pow2). Black shading indicates amino acid identity in at least three sequences, grey shading indicates the occurrence of different amino
acids with similar biochemical properties such as charge, size or hydrophobicity, and absence of shading indicates the presence of different amino acids with distinct
biochemical properties. Ampliﬁcation primers (PoTRA5 pair) are situated at the arrows, and are designed to maximise visible size differences in PCR products by gel
electrophoresis. Some Nigerian isolates of P. o. curtisi have an additional six amino acids in the repeat region (Poc + 6) (Sutherland et al., 2010). (B) Agarose gel showing size
distinction between Poc and Pow isolates after a single PCR using PoTRA5 primers. Fragment sizes: poctra = 317 bp; poctra + 6 = 335 bp; powtra = 245 bp. (a) shows four
isolates from Bioko Island, Equatorial Guinea (one Poc from Punta Europa, one Poc from Luba, two Pow from Luba) and four from Bogoigo, Uganda. Previously-characterised
isolates of each species from the UK Malaria Reference Laboratory are shown in (b).
Table 1
PCR Primer sequences and reaction conditions used for the ampliﬁcation of sequences encoding Plasmodium ovale sp. tryptophan-rich antigen (PoTRA) and P. ovale reticulocyte-
binding protein homologue (PoRBP2).
Gene Primer name Primer sequence PCR product size (bp) PCR cycling conditions (Thermocycler)
potra PoTRA fwd3
PoTRA rev3
50-GCACAAAAATGGTGCTAACC-30
50-ATCCATTTACCTTCCATTGC-30
787 95 C for 2 min; (95 C for 30 s; 58 C for 45 s; 72 C for 1 min)  44 cycles;
72 C for 5 min (TETRAD)
PoTRA fwd5
PoTRA rev5
50-ACGGCAAACCCGATAAACAC-30
50-GTGTTTGTAGTATTTACAGG-30
245
to
355
95 C for 2 min; (95 C for 30 s; 52 C for 45 s; 68 C for 1 min)  44 cycles;
68 C for 5 min (TETRAD)
porbp2 Porbp2TMfwd
Porbp2TMrev
50-TTGCAAACAAAAGTGCTCC-30
50-CCTAATTCTCTTTGT(G/A)CCC-30
120 95 C for 15 min; (95 C for 15 s; 53 C for 30 s; 68 C for 30 s)  40 cycles;
melt 55 to 95 C, 0.5 C steps, 5 s per step. (RG3000/RG6000)
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The potra gene sequences determined speciﬁcally for this study
were deposited in GenBank with accession numbers HM594180–
HM594183 inclusive.2.4. Ethics approval
LSHTM, UK (application No. 553809) and the Ugandan National
Council of Science and Technology granted ethics approval for the
study in Buliisa and Mayuge Districts, Uganda. Informed consent
was obtained in writing or by ﬁngerprint (in cases of illiteracy)
from all participating mothers on behalf of themselves and their
children.
Approval for the Bioko Island Malaria Indicator Survey was gi-
ven by the ethics committees of the Equatorial Guinea Ministry
of Health and Social Welfare, Malabo, and of LSHTM, UK (approval
number 5556). Written informed consent was given by each donor,
or in the case of young children, by their parent or caregiver.Ethics approval for the facility-based survey in Apac, Uganda,
was obtained from the medical biotechnology laboratories (MBL),
the national ethical committee of Uganda and LSHTM, UK (project
# 5539.09).
Approval for the collection of blood samples in the Republic of
Congo was obtained from the ethics committee at the Research
Institute of Microbial Diseases, Osaka University (Osaka, Japan),
and sampling was authorised by the administrative authority of
the Ministry for Research and the Ministry for Health in the Repub-
lic of the Congo. Written informed consent was obtained from indi-
vidual patients and antimalarial treatment was provided for all
individuals diagnosed with clinical malaria.
3. Results
3.1. Species discrimination by potra nested PCR
To identify a suitable genomic DNA sequence for discrimination
between the two species of P. ovale on the basis of differential sizes
of PCR ampliﬁcation products, the recently described gene potra
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P. o. curtisi and P. o. wallikeri isolates (Sutherland et al., 2010) using
the primers and conditions shown in Table 1. Sequences were
aligned in Clustal V, and were of four types (Fig. 1A). Two alleles
of the P. o. curtisi (poctra) gene were identiﬁed (Poc, Poc + 6), differ-
ing in six amino acids in the repeat region, as previously described.
Two P. o. walliker (powtra) alleles were observed (Pow1, Pow2),
differing in two non-synonymous positions. A small candidate
amplicon encompassing the variable repeat region was delineated
and ampliﬁed as described in Table 1 (Fig. 1A). Ampliﬁed products
from a number of clinical and ﬁeld isolates of P. ovale spp. were
compared by agarose gel electrophoresis, and the two species were
clearly distinguishable from each other (Fig. 1B).
3.2. Discrimination of poctra and powtra amplicons in ovale malaria
cases from Congo
To test the gel-based species discrimination assay, potra ampli-
ﬁcation assays were performed on a group of parasite isolates from
symptomatic malaria patients presenting to clinics in coastal
(Pointe-Noire), inland (Gamboma) and urban (Brazzaville) loca-
tions in the Republic of Congo. In total, 16 isolates had previously
been identiﬁed as P. ovale sp. on the basis of microscopy, and sevenTable 2
Prevalencea of Plasmodium ovale curtisi (Poc) and Plasmodium ovale wallikeri (Pow) among
Site Region, Country Number and nature
of samples investigated
Total with
Plasmodium
Pointe-Noire 2007 Congo 2 clinical cases,
ovale by microscopy
Gamboma 2006 Congo 2 clinical cases,
ovale by microscopy
Brazzaville 2005–6 Congo 2 clinical cases,
microscopy neg; ovale by
PCR
Luba Bioko Island,
Equatorial
Guinea
209
survey
36 by LAMP
Punta Europa
Scariba
Bioko Island,
Equatorial
Guinea
110
survey
13 by LAMP
Apac Apac District,
Uganda
241
all cause clinic attendees
89 by
microscopy
Bugoigo Buliisa
District,
Uganda
348
survey
202b
Walukuba Buliisa
District,
Uganda
312
survey
155b
Piida Buliisa
District,
Uganda
243
survey
141b
Bugoto Mayuge
District,
Uganda
392
survey
264b
Bukoba Mayuge
District,
Uganda
369
survey
279b
Lwanika Mayuge
District,
Uganda
203
survey
124b
TOTAL 2427
(excluding Congo)
1303
porbp2, gene encoding P. ovale reticulocyte-binding protein 2, qPCR, quantitative PCR; L
a As the precise sensitivity of our assays has not been determined, these are minimum
b Denominator of individuals with parasitaemia determined by real-time PCR.
c No P. ovale sp. infections identiﬁed.
d For one individual with each species, no result was obtained in the P. ovale sp. trypt
glyceraldehyde-3-phosphatase (pog3p) sequence analysis.additional samples were PCR-positive for P. ovale (Culleton et al.,
2009). We tested six of these isolates in the nested potra assay;
there were two P. o. curtisi from Brazzaville, the remaining four
isolates being identiﬁed as P. o. wallikeri (Table 2). For each of these
six isolates, the result obtained agreed with previous results from
ampliﬁcation of 18S ribosomal sequences conducted at the Univer-
sity of Nagasaki using the method of Snounou (Culleton et al.,
2008); microscopically identiﬁed ovale parasites failing to amplify
using the ‘‘classic’’ primer set were conﬁrmed to be P. o. wallikeri by
the potra discrimination assay.
These results demonstrate that this assay is capable of correctly
identifying P. o. curtisi and P. o. wallikeri in ﬁeld samples. Both spe-
cies are present in the Republic of Congo, but the only example of P.
o. curtisi was found in Brazzaville, more than 200 km from the two
sites in which P. o. wallikeri was identiﬁed. In addition, these iso-
lates were collected over a period of a few years. Therefore these
ﬁndings do not strictly rule out the possibility of geographic or
temporal barriers existing between the two P. ovale spp.
3.3. Species discriminationby porbp2quantitative PCR (qPCR)melt proﬁle
The genes encoding reticulocyte-binding protein 2 (porbp2) in
P. o. curtisi (pocrbp2) and P. o. wallikeri (powrbp2) (Sutherland et al.,sample sets investigated.
Results
(potra
nested PCR)
Results (porbp2
qPCR)
Ovale
infections
as proportion
of
all malaria
Population
prevalence
of ovale infections
2 Pow
2 Pow
2 Poc
1 Poc
2 Pow
1 Poc
2 Pow
8.3% 1.4%
1 Poc 1 Poc 7.7% 0.9%
5 Poc
1 Pow
5 Poc
1 Pow
6.7% 2.5%
1 Poc;
3 Pow
1 Poc;
3 Pow
2.0% 1.1%
0 Poc;
1 Pow
0 Poc;
1 Pow
0.6% 0.3%
0 Poc;
0 Pow
0 Poc;
0 Pow
0.0%c 0.0% c
1 Poc;
4 Pow
1 Poc;
4 Pow
1.9% 1.3%
6 Pocd;
10 Powd
6 Poc;
10 Pow
5.7% 4.3%
3 Poc;
1 Pow
3 Poc;
1 Pow
3.2% 2.0%
18 Poc;
22 Pow
18 Poc;
22 Pow
3.1% 1.6%
AMP, loop-activated ampliﬁcation.
estimates of prevalence.
ophan-rich antigen (potra) assay, but species designation was conﬁrmed by P. ovale
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with six single-nucleotide polymorphisms was identiﬁed, ﬂanked
by primers porbp2TMfwd and porb2TMrev (Table 1). In ﬁve of these
positions adenosine (A) or thymidine (T) residues in P. o. curtisiwere
replaced by cytosine (C) and guanidine (G) residues in P. o. wallikeri
(Fig. 2A). We therefore postulated that PCR amplicons based on this
regionwould differ inmelt proﬁle and designed a short amplicon to
test this idea.Melt-curve analysis of ampliconsdetected in real-time
by SYBR green incorporation, using a Corbett Rotorgene thermal
cycler, conﬁrmed that the peak melting temperature of the
P. o. curtisi amplicon was consistently one degree lower than that
of P. o. wallikeri in DNA from previously-characterised isolates of
each species (Fig. 2Aa), and in isolates from two children in Uganda,
collected within 2 days of each other in April 2009. potra PCR con-
ﬁrmed the species assignments made by the qPCR assay.
3.4. qPCR species discrimination in Uganda and Equatorial Guinea
For the 209 individuals surveyed in Luba and 110 from Punta
Europa Scariba, Bioko Island, DNA was extracted from each sample
and tested for the presence of Plasmodium spp. by LAMP (Polley
et al., 2010), and all LAMP positives were further evaluated using
species-speciﬁc nested PCR (Calderaro et al., 2007). In Luba, one
person was infected with P. falciparum and P. o. curtisi, and two
were infected with P. falciparum and P. o. wallikeri. One infected
individual from Punta Europa Scariba harboured P. falciparum,
Plasmodium malariae and P. o. curtisi.
In Apac District, P. ovale spp. infections were detected in six of
86 parasite positive blood samples of 241 clinic attendees. Ovale
parasites were found either as mono-infections (n = 3), or as
co-infections with P. falciparum (n = 2) or P. falciparum and
P. malariae (n = 1). Two P. ovale spp. mono-species infections were
incorrectly classiﬁed as P. falciparum infection by microscopy at
densities of 320 and 360 parasites/lL. These six were comprised
of ﬁve P. o. curtisi infections and one P. o. wallikeri infection.
Plasmodium ovale spp.-positive samples from the surveys in
Buliisa and Mayuge Districts were tested using the qPCR discrimi-
nation assay. Of 1850 individuals tested for malaria parasites of
any species, 30 were identiﬁed as harbouring P. ovale: 11 with P.A
B
Fig. 2. Discrimination between Plasmodium ovale curtisi and Plasmodium ovale wallike
(reticulocyte-binding protein 2) gene between ampliﬁcation primers Porbp2TMfwd a
mismatches (boxed) predicted to affect product Tm. (B) Output of melt analysis on a Ro
displaying clear discrimination between the two species: (a) the ampliﬁcation product of
peak at 74 C. (b) Melt proﬁles of isolates (M70C1, M02C2) from two children sampledo. curtisi and 19 with P. o. wallikeri. In each case, species identity
was conﬁrmed either by the potra amplicon polymorphism assay
or (for two individuals) by sequencing the pog3p P. ovale glyceral-
dehyde-3-phosphatase (pog3p) locus as previously described
(Sutherland et al., 2010).
Data from all sites are presented in Table 2.4. Discussion
This study has extended previous reports of sympatry between
the proposed species P. o. curtisi and P. o. wallikeri (Sutherland
et al., 2010) to the Republic of Congo, Equatorial Guinea and spe-
ciﬁc locations in three regions of Uganda. The utility of gel-based
and real-time qPCR-based ampliﬁcation assays is demonstrated,
deploying independent target sequences, for discrimination of
the two parasite species from ﬁeld samples collected on ﬁlter-pa-
per. Furthermore, in ﬁve locations in Uganda and in one of two vil-
lages on Bioko Island, surveys taken at a single time provided
examples of both species. Therefore we conclude there is no gen-
eral physical or temporal barrier preventing recombination of
these related parasite species, but rather that P. o. curtisi and P. o.
wallikerimaintain their distinct genetic identity through as yet un-
known biological mechanisms. These ﬁndings, which evaluated
two independent loci for species discrimination, conﬁrm the multi-
genic dimorphism of these two parasites across a broad geograph-
ical range, and thus further support the classiﬁcation of P. o. curtisi
and P. o. wallikeri as separate species.
The combined population prevalence of P. ovale spp. was found
to be between 1% and 6%, in Uganda and Equatorial Guinea, and
contributed alone or in combination with other Plasmodium spp.
to between 6% and 8% of malaria infections. This is consistent with
a recent analysis of 2588 malaria infections across Africa (Culleton
et al., 2008), entomological and parasitological surveys in Guinea-
Bissau (Snounou et al., 1993) and the ﬁnding of a higher than ex-
pected contribution of ovale malaria cases to imported disease in
both Portugal and the UK (Snounou et al., 1998; Sutherland et al.,
2010). We conclude that these two parasite species are both wide-
spread and, at least in Africa, fairly common. The contribution ofri using melt proﬁle differences. (A) Alignment of a 120 bp region of the porbp2
nd Porbp2TMrev of P. o. curtisi (pocrbp2) and P. o. wallikeri (powrbp2), showing
torgene thermo-cycler, expressed as the change in ﬂuorescence over time (dF/dT),
P. o. curtisi exhibits a melt peak at 73 C, whereas that of P. o. wallikeri exhibits a melt
in Uganda, each run in duplicate. All controls and samples were run in duplicate.
682 M.C. Oguike et al. / International Journal for Parasitology 41 (2011) 677–683cryptic ovale infections, in the form of both latent liver hypnozoites
and blood-stage infection below the level of PCR detection, is un-
known but almost certainly indicates that the actual prevalence
of P. ovale spp. infection in our study areas is higher than we have
observed. The contribution of these parasites to human malaria
infection has therefore been grossly over-looked, and it is hoped
that the simple molecular methods for diagnosis and discrimina-
tion devised here will go some way to assist in providing more
accurate estimates of the prevalence of ovale malaria in all ende-
mic areas. Although it is now well established that ovale malaria
occurs in Myanmar, Thailand, Vietnam and Cambodia (Tachibana
et al., 2002; Win et al., 2004; Sutherland et al., 2010), the extent
to which both P. o. curtisi and P. o. wallikeri have succeeded and
spread through southeast Asia and the south western Paciﬁc re-
mains an open question. Further, as we have not analysed potra
or porbp2 sequences from parasites in this region, the discrimina-
tion methods used here now require validation on southeast Asian
isolates. Of particular interest is the species diversity in Melanesian
communities in Indonesia, Papua New Guinea and the Solomon Is-
lands, where ovale malaria is likely to be widespread, if uncommon
and under-reported (Sutherland et al., 2010).
The most likely reason for the stable genetic separation be-
tween P. o. curtisi and P. o. wallikeri remains an evolutionary one;
that the two species represent separate transition events from
non-human to hominid primates sometime in the last 1–3 million
years (Sutherland et al., 2010). Such separate transitions would
have given the two lineages a period of evolution in isolation from
each other, and post-transition adaptation to the new host is unli-
kely to have proceeded in an identical fashion. It is expected there-
fore that the two species have accrued, through genetic drift,
sufﬁcient differences to prevent mating and recombination. The
global distribution of P. ovale spp. throughout the tropics strongly
suggests that any such polymorphisms will not be restricted by
host ethnicity, as a wide range of human populations are known
to be susceptible to ovale malaria.
One potential difference between P. o. curtisi and P. o. wallikeri
may be in host erythrocyte preference and it is theoretically possi-
ble that host polymorphisms such as blood groups restrict the two
parasites to separate human population compartments. This
hypothesis is not supported by two earlier studies that found
evidence of mixed infections of both types of P. ovale in three Thai
malaria patients (Zhou et al., 1998; Tachibana et al., 2002). These
studies detected genetic mixtures by sequencing of PCR amplicons
from the small ribosomal subunit genes. However, neither analysis
deployed a standard PCR method widely validated in other labora-
tories, and no quality control data or repeat results were presented
that could rule out PCR contamination as the source of the mixed
amplicons. Interestingly, Tachibana et al. (2002) went onto exam-
ine three additional dimorphic loci, pos25, pos28-1 and pos28-2, in
eight P. ovale patients but did not report any supporting evidence
from these loci that a mixed type infection was present in the
single individual identiﬁed as such by the ribosomal gene analysis.
Thus the presence of mixed infections of P. o. curtisi and
P. o. wallikeri in Thailand cannot be ruled out, but needs conﬁrma-
tion by multi-locus analyses such as those we have previously de-
scribed (Sutherland et al., 2010).
An alternative explanation for the apparent lack of recombina-
tion between P. o. curtisi and P. o. wallikeri is that the two parasite
species may differ in recognition molecules crucial for the mating
process, such as the ookinete proteins studied by Tachibana et al.
(2002). In this case it could be predicted that where both species
are common, mixed infections will occasionally occur, but that
these will not lead to successful cross-fertilisation and recombi-
nant forms following subsequent mosquito transmission. Detailed
epidemiological surveillance in Uganda, Nigeria and other areas
where P. o. curtisi and P. o. wallikeri occur together in approxi-mately equal proportions, may provide evidence that such mixed
infections occur – this would support the ﬁndings in Thailand
(mentioned previously in Section 4) and constitute strong evidence
against the hypothesis that the two species are kept apart by
mutually exclusive requirements for erythrocyte phenotype. Such
continuing detailed surveillance will also provide the opportunity
to further test our hypothesis that genetic recombination does
not occur between the two forms of ovale malaria investigated
here.
It is now important to focus on determining whether there are
any important biological, epidemiological or clinical differences
between the two ovale malaria parasites, such as relapse periodic-
ity (Davis et al., 2001; Coldren et al., 2007), drug response or trans-
missibility to different mosquito species. Only a thorough
understanding of these features can ensure that malaria elimina-
tion strategies, currently targeted at the greater threats posed by
falciparum and vivaxmalaria (Greenwood et al., 2008), are also able
to reduce or halt transmission of P. o. curtisi and P. o. wallikeri.Acknowledgements
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